BEAM
Beam Therapeutics Inc.
$37.92
+2.60 (+7.36%)
At close · Jul 7
Market Cap
$3.90B
Shares
102,879,214
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$139.74M
+120%
FY2025
Net Income
-$79.99M
+78.8%
FY2025
Operating Margin
-274.57%
+379.7pp
FY2025
Diluted EPS
-$0.81
+82.3%
FY2025
Operating Cash Flow
-$345.1M
+0.6%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| $164.01M | $139.74M | $63.52M | $377.71M | $60.92M | $51.84M | $24K | $18K | |
| $415.33M | $409.62M | $367.56M | $437.38M | $311.59M | $387.09M | $103.18M | $54.62M | |
| $120.31M | $113.82M | $111.53M | $116.81M | $87.81M | $57.22M | $29.61M | $20.55M | |
| $22.37M | $22.29M | $21.93M | $20.01M | $14.15M | $7.45M | $4.74M | $3.5M | |
| — | — | — | $6.49M | — | — | — | — | |
| $535.63M | $523.44M | $479.09M | $554.19M | $399.4M | $444.31M | $132.78M | $75.17M | |
| -$371.62M | -$383.69M | -$415.57M | -$176.49M | -$338.48M | -$392.47M | -$132.76M | -$75.15M | |
| — | -274.57% | -654.25% | -46.73% | -555.61% | -757.01% | -553166.67% | -417522.22% | |
| -$349.25M | -$361.4M | -$393.64M | -$156.47M | -$324.33M | -$385.01M | -$128.03M | -$71.65M | |
| $305.64M | $303.7M | $38.87M | $45.32M | $78.3M | $21.83M | -$61.83M | -$3.17M | |
| — | $255.15M | — | — | -$25.5M | — | — | — | |
| — | -$79.99M | -$376.7M | -$131.16M | -$260.18M | -$370.64M | -$194.59M | — | |
| — | $0 | $39K | $1.37M | $3.41M | $0 | $0 | $0 | |
| -$65.98M | -$79.99M | -$376.74M | -$132.53M | -$289.09M | -$370.64M | -$194.59M | -$78.33M | |
| — | -57.24% | -593.13% | -35.09% | -474.54% | -714.91% | -810800% | -435144.44% | |
| -$65.98M | -$79.99M | -$376.74M | -$132.53M | -$289.09M | -$370.64M | -$195.87M | -$91.04M | |
| -$67.21M | -$79.56M | -$376.67M | -$129.49M | -$291.47M | -$370.68M | -$194.62M | -$78.31M | |
| USD/shares | — | -$0.81 | -$4.58 | -$1.72 | -$4.13 | -$5.77 | -$4.19 | -$14.05 |
| USD/shares | — | -$0.81 | -$4.58 | -$1.72 | -$4.13 | -$5.77 | -$4.19 | -$14.05 |
| shares | — | 98.91M | 82.31M | 77.15M | 70.02M | 64.23M | 46.73M | 6.48M |
| shares | — | 98.91M | 82.31M | 77.15M | 70.02M | 64.23M | 46.73M | 6.48M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.